BCWORLD PHARM. Co., Ltd. - PE Ratio
200780.KQ
Price:
$3020
Market Cap:
$30.87B
BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical enterprise in South Korea, providing a comprehensive range of medical solutions. Its extensive product portfolio addresses diverse therapeutic areas, including the musculoskeletal system, digestive health, cardiovascular disorders, and central nervous system conditions. The company also supplies adrenocorticosteroids, narcotic analgesics, erectile dysfunction therapies, wellness injections, diuretics, antitussive expectorants, vaginitis treatments, anti-tuberculosis medications, anti-emetics, antiviral and antibiotic drugs, anti-malignant tumor agents, antifungal agents, antihistamines, antidotes, and antipyretic, analgesic, and anti-infl...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2014-12-15
Stock Exchange
KOE
Ticker
200780.KQ
PE Ratio
[-6.96]
ROE
[-4.08%]
Current Ratio
[0.53]
Dividend Yield
[3.31%]
Enterprise Value
[113.67B]
Dividend History
The PE Ratio as of August 2026 (TTM) for BCWORLD PHARM. Co., Ltd. (200780.KQ) is -6.96
According to BCWORLD PHARM. Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -6.96. This represents a change of -639.13% compared to the average of 1.29 of the last 4 quarters.
BCWORLD PHARM. Co., Ltd. (200780.KQ) Historical PE Ratio (quarterly & annually)
How has 200780.KQ PE Ratio performed in the past?
The mean historical PE Ratio of BCWORLD PHARM. Co., Ltd. over the last ten years is 10.39. The current -6.96 PE Ratio has changed -6795.68% with respect to the historical average. Over the past ten years (40 quarters), 200780.KQ's PE Ratio was at its highest in in the September 2023 quarter at 145.37. The PE Ratio was at its lowest in in the September 2022 quarter at -91.33.
Average
10.39
Median
4.89
Minimum
-115.55
Maximum
282.36
BCWORLD PHARM. Co., Ltd. (200780.KQ) PE Ratio by Quarter and Year
Discovering the peaks and valleys of BCWORLD PHARM. Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 61.47%
Maximum Annual PE Ratio = 282.36
Minimum Annual Increase = -522.98%
Minimum Annual PE Ratio = -115.55
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -10.46 | 6.68% |
| 2024 | -9.80 | -141.99% |
| 2023 | 23.34 | -91.73% |
| 2022 | 282.36 | -522.98% |
| 2021 | -66.76 | -42.23% |
| 2020 | -115.55 | 61.47% |
| 2019 | -71.56 | -335.51% |
| 2018 | 30.39 | 55.13% |
| 2017 | 19.59 | -12.52% |
| 2016 | 22.39 | -26.48% |
BCWORLD PHARM. Co., Ltd. (200780.KQ) Average PE Ratio
How has 200780.KQ PE Ratio performed in the past?
The current PE Ratio of BCWORLD PHARM. Co., Ltd. (200780.KQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.03
5-year avg
43.74
10-year avg
10.39
BCWORLD PHARM. Co., Ltd. (200780.KQ) PE Ratio vs. Peers
How is 200780.KQ’s PE Ratio compared to its peers?
BCWORLD PHARM. Co., Ltd.’s PE Ratio is less than Tdspharm (6.38), greater than Metacare Co., Ltd. (-10.95), greater than MYUNGMOON Pharm co.,Ltd (-20.13), greater than Hass (-186.98), greater than IVIM Technology (-15.96), less than Yuyu Pharma, Inc. (4.96), less than PharmGen Science, Inc. (-0.51), less than Xcell Therapeutics, Inc. (-1.68), less than Yuyu Pharma, Inc. (4.96), less than Gencurix, Inc. (-4.38),
| Company | PE Ratio | Market cap |
|---|---|---|
| 6.38 | $32.21B | |
| -10.95 | $22.71B | |
| -20.13 | $40.62B | |
| -186.98 | $39.05B | |
| -15.96 | $42.86B | |
| 4.96 | $52.93B | |
| -0.51 | $68.48B | |
| -1.68 | $21.29B | |
| 4.96 | $58.34B | |
| -4.38 | $40.48B |
Build a custom stock screener for BCWORLD PHARM. Co., Ltd. (200780.KQ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BCWORLD PHARM. Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BCWORLD PHARM. Co., Ltd. (200780.KQ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BCWORLD PHARM. Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is BCWORLD PHARM. Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for BCWORLD PHARM. Co., Ltd. (200780.KQ)?
What is the highest PE Ratio for BCWORLD PHARM. Co., Ltd. (200780.KQ)?
What is the 3-year average PE Ratio for BCWORLD PHARM. Co., Ltd. (200780.KQ)?
What is the 5-year average PE Ratio for BCWORLD PHARM. Co., Ltd. (200780.KQ)?
How does the current PE Ratio for BCWORLD PHARM. Co., Ltd. (200780.KQ) compare to its historical average?